Content about Cognitive disorders

April 4, 2013
Dementia costs more to treat than heart disease or cancer, study finds

The annual cost of treating dementia in the United States ranges from $157 billion to $215 billion, according to a new study by the RAND Corp.

NEW YORK — The annual cost of treating dementia in the United States ranges from $157 billion to $215 billion, according to a new study by the RAND Corp.

The research organization said that number meant dementia costs more to treat than cancer or heart disease, with the greatest cost coming from institutional and home-based long-term care, as opposed to medical services.

April 6, 2012
Sam's Club offers screenings for brain health

Sam's Club is offering free screenings for brain health at all of its stores that operate pharmacies this month, the retailer said Friday.

BENTONVILLE, Ark. — Sam's Club is offering free screenings for brain health at all of its stores that operate pharmacies this month, the retailer said Friday.

The company, which has performed more than 1 million health and wellness screenings at it stores since 2011, said it would offer the screenings on April 14 for members and the public, including a memory test and educational materials on Alzheimer's and dementia provided by the Alzheimer's Foundation of America, as well as body mass index, blood pressure and glucose tests.

September 21, 2011
Diabetes may increase risk of developing dementia, study finds

A study published in the Sept. 20 issue of Neurology, the medical journal of the American Academy of Neurology, found a link between diabetes and the development of dementia.

NEW YORK — A study published in the Sept. 20 issue of Neurology, the medical journal of the American Academy of Neurology, found a link between diabetes and the development of dementia.

November 3, 2010
PhRMA: Alzheimer’s drug market continues to expand

Nearly 100 drugs are in development for treating Alzheimer’s disease, according to a new report...

WASHINGTON Nearly 100 drugs are in development for treating Alzheimer’s disease, according to a new report by the main lobby for the pharmaceutical industry.

 

The Pharmaceutical Research and Manufacturers of America said 98 medicines for dementia, mostly Alzheimer’s, were in clinical trials or under review by the Food and Drug Administration.

 

 

July 5, 2010
Caraco launches generic dementia treatment

Generic drug maker Caraco Pharmaceutical Labs has begun shipping a drug for treating dementia, Caraco...

March 7, 2010
Study: Dementia may be triggered by depression in diabetics

Diabetic adults with depression are twice as likely to develop dementia, according to a new...